SHR-1905

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for SHR-1905, covering 2024-06-21 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]

See pricing